A research team at Yale university are investigating ways to improve a type of treatment known as CAR-T therapy. The treatment involves reprogramming the patient’s own immune system cells to fight cancer in the brain.
What Was Found?
Using scanning technology, cells in the brain were observed by the research team. In doing so, they identified an enzyme which boosts the productivity of tumour-attacking cells.
The effectiveness of immunotherapy treatment has historically diminished over time, hence this discovery could help the immune response to fight cancer cells for a longer duration. Overall, this may improve the effectiveness of the treatment as well as potentially being a useful tool to help treat other cancers.
Researchers now believe that the possibility of producing these more active cells may lead to this treatment outperforming existing cell therapies. Future clinical research can now look further into how effective this treatment may be for the community, potentially making the method a part of a newly approved cell therapy.
For more scientific information about the study, click here.
If you would like to use your experience and insight to support clinical research, consider signing up to be a PRIME advocate for brainstrust.
If you or someone you love is living with a brain tumour and have any questions around this latest news, or want to access support, give us a call on 01983 292 405 or email email@example.com. You can also visit our little brainstrust website which features support for children affected by brain tumour.